Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch & Lomb (BLCO) Asset Writedowns and Impairment (2021 - 2024)

Bausch & Lomb (BLCO) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with $1.0 million as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Asset Writedowns and Impairment fell 87.5% year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Sep 2023, down 50.0%, and an annual FY2024 reading of $5.0 million, changed N/A over the prior year.
  • Asset Writedowns and Impairment was $1.0 million for Q3 2022 at Bausch & Lomb, roughly flat from $1.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $8.0 million in Q3 2021 and bottomed at $1.0 million in Q1 2021.